Clinical Trials Logo

Portal Caver Cavernoma clinical trials

View clinical trials related to Portal Caver Cavernoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04525768 Not yet recruiting - Portal Hypertension Clinical Trials

Gastroesophageal Varices in Cavernoma

Start date: October 1, 2020
Phase:
Study type: Observational

Myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, may lead to gastroesophageal varices. The quality of life, morbidity, and mortality of MPN patients mainly depend on disease-related symptoms, thromboembolic and hemorrhagic complications. Previous studies have shown that JAK2 V617F has a prominent role in vascular risk and MPN-associated gastroesophageal varices. Portal vein thrombosis and portal cavernoma frequently occur in the MPN population and the management of gastroesophageal varices in these patients are sometimes technically difficult. The aim of this study is to investigate the the characteristics of patients with gastroesophageal varices and portal caver cavernoma with or without JAK2 mutation.